Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 93

1.

Cerebral patterns of neuropsychological disturbances in hepatitis C patients.

Prell T, Dirks M, Arvanitis D, Braun D, Peschel T, Worthmann H, Schuppner R, Raab P, Grosskreutz J, Weissenborn K.

J Neurovirol. 2019 Jan 4. doi: 10.1007/s13365-018-0709-2. [Epub ahead of print]

PMID:
30610739
2.

Disease progression impacts health-related quality of life in amyotrophic lateral sclerosis.

Prell T, Gaur N, Stubendorff B, Rödiger A, Witte OW, Grosskreutz J.

J Neurol Sci. 2018 Dec 28;397:92-95. doi: 10.1016/j.jns.2018.12.035. [Epub ahead of print]

PMID:
30597420
3.

Investigation of mitochondrial calcium uniporter role in embryonic and adult motor neurons from G93AhSOD1 mice.

Tadić V, Adam A, Goldhammer N, Lautenschlaeger J, Oberstadt M, Malci A, Le TT, Sengupta S, Stubendorff B, Keiner S, Witte OW, Grosskreutz J.

Neurobiol Aging. 2018 Nov 23;75:209-222. doi: 10.1016/j.neurobiolaging.2018.11.019. [Epub ahead of print]

PMID:
30597405
4.

Developing a Neuroimaging Biomarker for Amyotrophic Lateral Sclerosis: Multi-Center Data Sharing and the Road to a "Global Cohort".

Steinbach R, Gaur N, Stubendorff B, Witte OW, Grosskreutz J.

Front Neurol. 2018 Dec 4;9:1055. doi: 10.3389/fneur.2018.01055. eCollection 2018. Review.

5.

Interferon-γ Receptor 1 and GluR1 upregulated in motor neurons of symptomatic hSOD1G93A mice.

Sengupta S, Le TT, Adam A, Tadić V, Stubendorff B, Keiner S, Kloss L, Prell T, Witte OW, Grosskreutz J.

Eur J Neurosci. 2018 Nov 20. doi: 10.1111/ejn.14276. [Epub ahead of print]

PMID:
30457201
6.

Neurofascin-155 IgM autoantibodies in patients with inflammatory neuropathies.

Doppler K, Stengel H, Appeltshauser L, Grosskreutz J, Man Ng JK, Meinl E, Sommer C.

J Neurol Neurosurg Psychiatry. 2018 Nov;89(11):1145-1151. doi: 10.1136/jnnp-2018-318170. Epub 2018 Jun 26.

PMID:
29945879
7.

Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.

Ludolph AC, Schuster J, Dorst J, Dupuis L, Dreyhaupt J, Weishaupt JH, Kassubek J, Weiland U, Petri S, Meyer T, Grosskreutz J, Schrank B, Boentert M, Emmer A, Hermann A, Zeller D, Prudlo J, Winkler AS, Grehl T, Heneka MT, Wollebæk Johannesen S, Göricke B; RAS-ALS Study Group.

Lancet Neurol. 2018 Aug;17(8):681-688. doi: 10.1016/S1474-4422(18)30176-5. Epub 2018 Jun 19.

PMID:
29934198
8.

Comprehensive analysis of the mutation spectrum in 301 German ALS families.

Müller K, Brenner D, Weydt P, Meyer T, Grehl T, Petri S, Grosskreutz J, Schuster J, Volk AE, Borck G, Kubisch C, Klopstock T, Zeller D, Jablonka S, Sendtner M, Klebe S, Knehr A, Günther K, Weis J, Claeys KG, Schrank B, Sperfeld AD, Hübers A, Otto M, Dorst J, Meitinger T, Strom TM, Andersen PM, Ludolph AC, Weishaupt JH; German ALS network MND-NET.

J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):817-827. doi: 10.1136/jnnp-2017-317611. Epub 2018 Apr 12.

PMID:
29650794
9.

Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.

Westeneng HJ, Debray TPA, Visser AE, van Eijk RPA, Rooney JPK, Calvo A, Martin S, McDermott CJ, Thompson AG, Pinto S, Kobeleva X, Rosenbohm A, Stubendorff B, Sommer H, Middelkoop BM, Dekker AM, van Vugt JJFA, van Rheenen W, Vajda A, Heverin M, Kazoka M, Hollinger H, Gromicho M, Körner S, Ringer TM, Rödiger A, Gunkel A, Shaw CE, Bredenoord AL, van Es MA, Corcia P, Couratier P, Weber M, Grosskreutz J, Ludolph AC, Petri S, de Carvalho M, Van Damme P, Talbot K, Turner MR, Shaw PJ, Al-Chalabi A, Chiò A, Hardiman O, Moons KGM, Veldink JH, van den Berg LH.

Lancet Neurol. 2018 May;17(5):423-433. doi: 10.1016/S1474-4422(18)30089-9. Epub 2018 Mar 26.

10.

Dysregulation of chemokine receptor expression and function in leukocytes from ALS patients.

Perner C, Perner F, Stubendorff B, Förster M, Witte OW, Heidel FH, Prell T, Grosskreutz J.

J Neuroinflammation. 2018 Mar 28;15(1):99. doi: 10.1186/s12974-018-1135-3.

11.

The metabolic and endocrine characteristics in spinal and bulbar muscular atrophy.

Rosenbohm A, Hirsch S, Volk AE, Grehl T, Grosskreutz J, Hanisch F, Herrmann A, Kollewe K, Kress W, Meyer T, Petri S, Prudlo J, Wessig C, Müller HP, Dreyhaupt J, Weishaupt J, Kubisch C, Kassubek J, Weydt P, Ludolph AC.

J Neurol. 2018 May;265(5):1026-1036. doi: 10.1007/s00415-018-8790-2. Epub 2018 Feb 20.

PMID:
29464380
12.

Provision of assistive technology devices among people with ALS in Germany: a platform-case management approach.

Funke A, Spittel S, Grehl T, Grosskreutz J, Kettemann D, Petri S, Weyen U, Weydt P, Dorst J, Ludolph AC, Baum P, Oberstadt M, Jordan B, Hermann A, Wolf J, Boentert M, Walter B, Gajewski N, Maier A, Münch C, Meyer T.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Aug;19(5-6):342-350. doi: 10.1080/21678421.2018.1431786. Epub 2018 Jan 30.

PMID:
29382225
13.

Hot-spot KIF5A mutations cause familial ALS.

Brenner D, Yilmaz R, Müller K, Grehl T, Petri S, Meyer T, Grosskreutz J, Weydt P, Ruf W, Neuwirth C, Weber M, Pinto S, Claeys KG, Schrank B, Jordan B, Knehr A, Günther K, Hübers A, Zeller D, Kubisch C, Jablonka S, Sendtner M, Klopstock T, de Carvalho M, Sperfeld A, Borck G, Volk AE, Dorst J, Weis J, Otto M, Schuster J, Del Tredici K, Braak H, Danzer KM, Freischmidt A, Meitinger T, Strom TM, Ludolph AC, Andersen PM, Weishaupt JH; German ALS network MND-NET .

Brain. 2018 Mar 1;141(3):688-697. doi: 10.1093/brain/awx370.

14.

Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis.

Feneberg E, Oeckl P, Steinacker P, Verde F, Barro C, Van Damme P, Gray E, Grosskreutz J, Jardel C, Kuhle J, Koerner S, Lamari F, Amador MDM, Mayer B, Morelli C, Muckova P, Petri S, Poesen K, Raaphorst J, Salachas F, Silani V, Stubendorff B, Turner MR, Verbeek MM, Weishaupt JH, Weydt P, Ludolph AC, Otto M.

Neurology. 2018 Jan 2;90(1):e22-e30. doi: 10.1212/WNL.0000000000004761. Epub 2017 Dec 6.

PMID:
29212830
15.

July 2017 ENCALS statement on edaravone.

Al-Chalabi A, Andersen PM, Chandran S, Chio A, Corcia P, Couratier P, Danielsson O, de Carvalho M, Desnuelle C, Grehl T, Grosskreutz J, Holmøy T, Ingre C, Karlsborg M, Kleveland G, Koch JC, Koritnik B, KuzmaKozakiewicz M, Laaksovirta H, Ludolph A, McDermott C, Meyer T, Mitre Ropero B, Mora Pardina J, Nygren I, Petri S, Povedano Panades M, Salachas F, Shaw P, Silani V, Staaf G, Svenstrup K, Talbot K, Tysnes OB, Van Damme P, van der Kooi A, Weber M, Weydt P, Wolf J, Hardiman O, van den Berg LH.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):471-474. doi: 10.1080/21678421.2017.1369125. Epub 2017 Oct 4. Review. No abstract available.

16.

DNA strand breaks and TDP-43 mislocation are absent in the murine hSOD1G93A model of amyotrophic lateral sclerosis in vivo and in vitro.

Penndorf D, Tadić V, Witte OW, Grosskreutz J, Kretz A.

PLoS One. 2017 Aug 23;12(8):e0183684. doi: 10.1371/journal.pone.0183684. eCollection 2017.

17.

'It's the progression, doctor': what patients with motor neurone disease really are interested in.

Grosskreutz J.

J Neurol Neurosurg Psychiatry. 2017 Nov;88(11):897. doi: 10.1136/jnnp-2017-316001. Epub 2017 Jul 28. No abstract available.

18.

Sigma 1 receptor activation modifies intracellular calcium exchange in the G93AhSOD1 ALS model.

Tadić V, Malci A, Goldhammer N, Stubendorff B, Sengupta S, Prell T, Keiner S, Liu J, Guenther M, Frahm C, Witte OW, Grosskreutz J.

Neuroscience. 2017 Sep 17;359:105-118. doi: 10.1016/j.neuroscience.2017.07.012. Epub 2017 Jul 16.

PMID:
28723387
19.

International Survey of ALS Experts about Critical Questions for Assessing Patients with ALS.

De Carvalho M, Ryczkowski A, Andersen P, Gromicho M, Grosskreutz J, Kuźma-Kozakiewicz M, Petri S, Piotrkiewicz M, Miltenberger Miltenyi G.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):505-510. doi: 10.1080/21678421.2017.1349150. Epub 2017 Jul 13.

PMID:
28705085
20.

Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease.

Poesen K, De Schaepdryver M, Stubendorff B, Gille B, Muckova P, Wendler S, Prell T, Ringer TM, Rhode H, Stevens O, Claeys KG, Couwelier G, D'Hondt A, Lamaire N, Tilkin P, Van Reijen D, Gourmaud S, Fedtke N, Heiling B, Rumpel M, Rödiger A, Gunkel A, Witte OW, Paquet C, Vandenberghe R, Grosskreutz J, Van Damme P.

Neurology. 2017 Jun 13;88(24):2302-2309. doi: 10.1212/WNL.0000000000004029. Epub 2017 May 12.

PMID:
28500227

Supplemental Content

Loading ...
Support Center